The FDA seems highly unlikely to approve the Covaxin vaccine, making OCGN stock an excellent name to short going forward. More
Articles
The Metals Company’s Pilot Program Proves It’s Worth Your Attention
TMC stock could skyrocket as it may have found a profitable new way to recover metals required for electric vehicles. More
3 Stocks Insiders Are Snapping Up. Do They Know Something We Don’t?
Insider trading is heavily regulated, but it still happens, and it's worth paying attention to big moves from insiders for potential profits. More
Despite Critics, Thoughtworks Still Has Upside Given Its Growth and Profitability
Despite critics, Thoughtworks still has upside. TWKS stock could rise 38% to $38.75 if its sales, cash flow, and margins keep growing. More
ChargePoint Stock May Start Gunning for Analysts’ Price Targets
CHPT stock has fallen out of favor in recent months, but it may be poised for a fast comeback given the rapidly expanding EV landscape. More
Crypto Stocks: Why BTBT, SOS, MARA, CAN Stocks Are Minting Gains on Tuesday
Today, a wide range of crypto stocks are moving higher as investors appear willing to take a risk-on approach to the markets right now. More
